Ernexa Therapeutics (ERNA) Financials: Revenue & Earnings

ERNA price $1.97 -0.03 -1.38%

Ticker
ERNA
Price
$1.97
Change
-0.03 -1.38%
Market cap ?
$3.21M
P/E ?
-0.11
Dividend yield ?
0.00%
Beta ?
2.65
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
22312000212740002333500019806000000680005820000

Ernexa Therapeutics Inc. is a biotechnology firm currently in its preclinical development phase, specializing in the creation of therapeutic interventions using induced mesenchymal stem cells (iMSCs). The company's primary focus lies in addressing solid tumor cancers and a range of autoimmune diseases. Its flagship candidate, ERNA-101, is an allogeneic iMSC designed to release pro-inflammatory cytokines, namely IL-7…

Fair value

ERNA fair value Not meaningful. Price $1.97.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ERNA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-06—-3.84——
2026-08-06-3.40-3.30——
2026-05-11-6.95-1.95——
2026-03-13-0.25———
2025-11-07-0.15-33.00——
2025-08-13-0.61-39.00——
2025-05-07-2.25-48.00——
2025-03-13-48.00-37.501.00K—
2024-11-12-0.74-0.24487.00K—
2024-08-13-15.29—47.00K—
2024-05-13-18.44—47.00K—
2024-03-14-17.09—17.00K—
2023-11-13-15.44—51.00K—
2023-08-11-12.74———
2023-05-11-1.06———
2023-03-20-464.77-900.00——
2022-11-14-2.49-2.20——
2022-08-11-1.20-2.60——
2022-07-01-3.40-2.80——
2022-04-15-3.20-2.50——
2021-11-09-2.20-1.60——
2021-08-16-1,800.001.01—6.20M
2021-05-17-318.50-1.20—6.14M
2021-03-11-40.00-1.20—6.13M
2020-11-11-24.258.00—7.16M
2020-08-07-24.50———
2020-05-19-12.25———
2020-03-19———6.20M
2019-10-10—-1.20—6.13M
2019-03-204.406.00——
2018-11-073.20-1.60——
2018-08-02-2.00-9.20——
2018-05-09-6.40-10.80——
2018-03-06-10.00-5.60——
2017-11-07-2.80-8.40——
2017-08-02-2.80-14.00——
2017-05-03-1.60-15.60——
2017-03-06-8.80-7.60——
2016-11-08-12.40-19.20——
2016-08-03-18.40-20.80——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-14Spiegel Robert J.Other0——
2026-08-31Bristol James ArthurBuy8.32K$4.5738.02K
2026-08-31Bristol James ArthurBuy5.08K$4.5723.23K
2026-08-31Cicala PeterBuy5.94K$4.5727.16K
2026-08-31Cicala PeterBuy5.08K$4.5723.23K
2026-08-31Polinsky DavidBuy5.08K$4.5723.23K
2026-08-31Wexler William A.Buy5.94K$4.5727.16K
2026-08-31Ratner ElenaBuy5.94K$4.5727.16K
2026-08-31Luther SanjeevBuy118.85K$4.57543.14K
2026-08-04Polinsky DavidOther0——
2026-02-10Polinsky DavidOther8.00K$17.00136.00K
2026-02-10Cherington CharlesBuy4.00M$0.502.00M
2026-02-10Cherington CharlesBuy4.00M$0.682.72M
2025-06-21Gurrola Sandra MBuy30——
2025-06-21Gurrola Sandra MBuy30——
2025-06-09Cherington CharlesBuy21.24M$0.102.22M
2025-04-02Cherington CharlesBuy3.77M$0.10394.17K
2025-02-07Wexler William A.Buy124.53K$0.3442.34K
2025-02-07Gurrola Sandra MBuy150.00K$0.3451.00K
2025-02-07Bristol James ArthurBuy72.07K$0.3424.51K
2025-02-07Cicala PeterBuy51.48K$0.3417.50K
2025-02-07Luther SanjeevBuy1.12M$0.34381.94K
2025-01-13Ratner ElenaBuy140.08K$0.3042.02K
2025-01-07Ratner ElenaOther0——
2024-10-29Cherington CharlesBuy2.82M$0.501.41M
2024-10-29Cherington CharlesBuy5.42M$1.005.42M
2024-10-29Cherington CharlesBuy4.77M$1.004.77M
2024-10-29Cherington CharlesSell0$0.500
2024-09-24Cherington CharlesBuy1.56M$1.432.24M
2024-09-24Cherington CharlesBuy5.42M——
2024-09-24Cherington CharlesBuy1.24M$1.431.77M
2024-09-24Cherington CharlesBuy4.77M——
2024-09-24Cherington CharlesBuy261.76K$1.43374.31K
2024-09-24Cherington CharlesSell3.13M$1.434.47M
2024-09-24Cherington CharlesSell0$1.920
2024-09-24Cherington CharlesSell0$2.860
2024-09-24Cherington CharlesBuy0$0.500
2024-09-23Cherington CharlesBuy83.92K$1.43120.00K
2024-09-23Cherington CharlesBuy83.92K$1.43120.00K
2024-09-23Cherington CharlesBuy0$2.860
2024-06-21Gurrola Sandra MBuy437——
2024-06-21Gurrola Sandra MSell180$1.94349
2024-06-21Gurrola Sandra MSell437——
2024-04-26Cicala PeterBuy88.95K$1.74154.77K
2024-04-26Gurrola Sandra MBuy80.00K$1.74139.20K
2024-04-26Bristol James ArthurBuy124.53K$1.74216.67K
2024-02-12Cicala PeterOther0——
2024-01-01Luther SanjeevBuy1.69M$1.803.03M
2024-01-01Clarke Dorothy JBuy168.52K$1.80303.34K
2024-01-01Luther SanjeevOther0——
2023-12-15Freebird Partners LPBuy1.04M$1.431.49M
2023-12-15Freebird Partners LPBuy521.00K$1.921000.00K
2023-12-14Cherington CharlesBuy3.13M$1.434.47M
2023-12-14Cherington CharlesBuy2.31M$1.433.30M
2023-12-14Cherington CharlesBuy523.51K$1.43748.62K
2023-12-14Cherington CharlesBuy0$1.920
2023-12-14Cherington CharlesSell523.51K$3.281.72M
2023-12-14Cherington CharlesSell2.31M$2.616.02M
2023-12-14Freebird Partners LPBuy524.47K$1.43750.00K
2023-12-14Freebird Partners LPBuy424.93K$3.281.39M
2023-12-14Freebird Partners LPBuy524.47K$2.611.37M
2023-10-30Bristol James ArthurOther0——
2023-08-28Clarke Dorothy JOther0——
2023-08-08BINDER BRANTOther0——
2023-08-08WAGNER RICHARD WOther0——
2023-07-14Freebird Partners LPBuy524.47K$2.611.37M
2023-07-14Freebird Partners LPBuy262.24K$2.86750.00K
2023-07-13Cherington CharlesBuy2.31M$2.616.02M
2023-07-13Cherington CharlesBuy0$2.860
2023-07-13BINDER BRANTBuy83.92K$2.61219.02K
2023-07-13BINDER BRANTBuy0$2.860
2023-07-13WAGNER RICHARD WBuy83.92K$2.61219.02K
2023-07-13WAGNER RICHARD WBuy0$2.860
2023-07-06WAGNER RICHARD WOther0——
2023-07-06BINDER BRANTOther0——
2023-06-21Gurrola Sandra MBuy438——
2023-06-21Gurrola Sandra MSell179$2.48444
2023-06-21Gurrola Sandra MSell438——
2023-06-02Freebird Partners LPSell424.93K$3.281.39M
2023-04-03Freebird Partners LPSell0——
2023-01-12Angel MatthewBuy132.00K——
2022-12-02DENNY GEORGE P IIIOther0——
2022-12-02DENNY GEORGE P IIIOther0——
2022-12-02DENNY GEORGE P IIISell0——
2022-12-02DENNY GEORGE P IIIOther2.97K——
2022-12-02Cherington CharlesBuy261.76K$3.28858.56K
2022-12-02Cherington CharlesBuy523.51K$0.1265.44K
2022-12-02Singer Nicholas JasonBuy424.93K$0.1253.12K
2022-12-02Singer Nicholas JasonBuy212.46K$3.28696.88K
2022-12-02Singer Nicholas JasonBuy141.64K$0.1217.71K
2022-12-02Singer Nicholas JasonBuy70.82K$3.28232.30K
2022-12-02HALPERN JOHN DBuy671.84K$0.1283.98K
2022-12-02HALPERN JOHN DBuy335.92K$3.281.10M
2022-09-20Sidhu RogerSell20.16K——
2022-09-20Sidhu RogerBuy20.16K——
2022-08-01Angel MatthewBuy2.49M——
2022-08-01Cherington CharlesBuy215.10K——
2022-08-01Fiore GregoryBuy95.10K——
2022-08-01Wexler William A.Buy165.80K——
2022-08-01Singer Nicholas JasonBuy165.80K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 9, holders -10 vs prior quarter. Ownership 3.00%.

HolderSharesChangeChange %Value
CITADEL ADVISORS LLC15.10K-17.97K-54.34%100.44K
VANGUARD FIDUCIARY TRUST CO8.34K-17.11K-67.24%55.43K
DAUNTLESS INVESTMENT GROUP, LLC6.00K-606.44K-99.02%39.90K
VANGUARD CAPITAL MANAGEMENT LLC5.68K-20.82K-78.55%37.80K
TRADEWINDS CAPITAL MANAGEMENT, LLC361361New2.40K
BLACKROCK, INC.33-787-95.98%219
ASSETMARK, INC5-128-96.24%33
SBI SECURITIES CO., LTD.1-5-83.33%7
BNP PARIBAS FINANCIAL MARKETS1-9-90.00%7
WARBERG ASSET MANAGEMENT LLC0-50.00K-100.00%0
MONTAG A & ASSOCIATES INC0-8-100.00%0
BLEICHROEDER LP0-2.00M-100.00%0
XTX TOPCO LTD0-54.34K-100.00%0
SBI SECURITIES CO., LTD.0-6-100.00%0
ACTIVEST WEALTH MANAGEMENT0-3-100.00%0
CORIENT PRIVATE WEALTH LP0-438.09K-100.00%0
BLACKROCK, INC.0-820-100.00%0
DAUNTLESS INVESTMENT GROUP, LLC0-612.44K-100.00%0
VANGUARD CAPITAL MANAGEMENT LLC0-26.50K-100.00%0
UBS GROUP AG0-21.23K-100.00%0
GOLDMAN SACHS GROUP INC0-16.63K-100.00%0
VANGUARD FIDUCIARY TRUST CO0-25.45K-100.00%0
BNP PARIBAS FINANCIAL MARKETS0-10-100.00%0
GEODE CAPITAL MANAGEMENT, LLC0-244.45K-100.00%0
ASSETMARK, INC0-133-100.00%0

Earnings and financials

Ernexa Therapeutics Inc. (ERNA) trades at $1.97, with a market cap of $3.21M and a trailing P/E of -0.11. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
22312000212740002333500019806000000680005820000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Ernexa Therapeutics (ERNA) Financials: Revenue & Earnings

ERNA$1.97-0.03 -1.38%

$3.21M

Market Cap

-0.11

P/E

—

Forward P/E

—

Score

Price History